文献速递神经肿瘤小儿神经外科与脑积水

接受序贯大剂量化疗与放疗豁免策略治疗的髓母细胞瘤幼儿的长期神经心理学随访

Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
PubMed 文献 · J Neurooncol · 2017-04-12

这项回顾性研究纳入1998至2011年北美7家机构收治的诊断时不足6岁、按CCG 99703方案化疗方案接受大剂量化疗策略治疗的髓母细胞瘤患儿,24例有治疗后神经心理学评估。平均诊断年龄29.4个月,37.5%接受放疗,平均评估于诊断后3.5年,全量表智商均值92(SD=16.8),74%为低平均至平均神经心理学功能,25%在至少一个领域存在临床显著缺陷。

要点

  • 24例患儿中74%神经心理学功能处于低平均至平均范围,25%在至少一个领域存在临床显著缺陷。
  • 接受放疗、需要听力支持或发生后颅窝综合征的幼儿神经认知结局更差。
  • 全量表智商范围56至119,均值92(SD=16.8),平均于诊断后3.5年(SD=1.8)评估。

核心结论

  • 接受序贯大剂量化疗且约三分之一接受放疗的幼儿髓母细胞瘤幸存者,神经心理学功能总体处于平均正常范围内,但近25%在特定领域存在显著缺陷。

研究设计与样本

  • 回顾性研究纳入1998至2011年北美7家机构收治的诊断时不足6岁、按CCG 99703方案化疗方案接受大剂量化疗策略治疗的髓母细胞瘤患儿,24例有至少一次治疗后神经心理学评估者纳入分析。

主要发现

  • 24例中15例(63%)为男性,诊断时平均年龄29.4个月(SD=13.5),5例(21%)报告后颅窝综合征,9例(37.5%)接受放疗(5例局灶、4例颅脊髓)。
  • 患儿平均于诊断后3.5年(SD=1.8)接受评估,全量表智商范围56至119,均值92(SD=16.8)。
  • 74%的患儿神经心理学功能为低平均至平均。
  • 接受放疗、需要听力支持或发生后颅窝综合征的极年幼患儿神经认知结局更差。
  • 25%的患儿在至少一个神经心理学功能领域存在临床显著缺陷(低于第10百分位)。

临床怎么用

  • 作者指出,接受序贯大剂量化疗且约三分之一接受放疗的幼儿髓母细胞瘤幸存者神经心理学功能总体处于平均正常范围内,但近25%在特定领域存在显著缺陷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-dose chemotherapy (HDC) strategies were developed in brain tumor protocols for young children to prevent neuropsychological (NP) impairments associated with radiotherapy. However, comprehensive NP evaluations of these children treated with such strategies remain limited. We examined the long-term neurocognitive outcomes of young children (<6 years) with medulloblastoma, treated similarly, with a HDC strategy "according to" the chemotherapy regimen of the protocol CCG 99703. This retrospective study included young children less than 6 years of age at diagnosis of medulloblastoma treated from 1998 to 2011 at 7 North American institutions. Twenty-four patients who had at least one NP assessment post-treatment are the focus of the current study. Of 24 patients in this review, 15 (63%) were male and the mean age at diagnosis was 29.4 months (SD = 13.5). Posterior fossa syndrome (PFs) was reported in five patients (21%). Nine (37.5%) received radiotherapy (5 focal, 4 craniospinal). On average, children were assessed 3.5 years (SD = 1.8) post-diagnosis, and full-scale intellectual quotient (FSIQ) scores ranged from 56 to 119 ([Formula: see text]= 92; SD = 16.8). The majority of children (74%) had low-average to average NP functioning. Very young children treated with radiotherapy, who needed hearing support or with PFs had worse neurocognitive outcomes. Clinically significant deficits (<10th percentile) in at least one area of NP functioning were found in 25% of the children. NP data obtained from this sample of survivors of medulloblastoma in early childhood, all treated with sequential HDC and 1/3 with radiotherapy, describe NP functioning within average normal limits overall. However, almost 25% of children had significant deficits in specific domains.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Fay-McClymont TB, Ploetz DM, Mabbott D, et al. Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach. J Neurooncol. 2017. PMID: 28405869. doi:10.1007/s11060-017-2409-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。